NO20002189D0 - Use of macrolides for the treatment of cancer and mucous degeneration - Google Patents
Use of macrolides for the treatment of cancer and mucous degenerationInfo
- Publication number
- NO20002189D0 NO20002189D0 NO20002189A NO20002189A NO20002189D0 NO 20002189 D0 NO20002189 D0 NO 20002189D0 NO 20002189 A NO20002189 A NO 20002189A NO 20002189 A NO20002189 A NO 20002189A NO 20002189 D0 NO20002189 D0 NO 20002189D0
- Authority
- NO
- Norway
- Prior art keywords
- macrolides
- mucous
- degeneration
- cancer
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 230000007850 degeneration Effects 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 229940041033 macrolides Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96147397A | 1997-10-31 | 1997-10-31 | |
| PCT/US1998/023043 WO1999022722A2 (en) | 1997-10-31 | 1998-10-30 | Use of macrolides for the treatment of cancer and macular degeneration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20002189D0 true NO20002189D0 (en) | 2000-04-27 |
| NO20002189L NO20002189L (en) | 2000-06-28 |
Family
ID=25504514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002189A NO20002189L (en) | 1997-10-31 | 2000-04-27 | Use of macrolides for the treatment of cancer and mucous degeneration |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1027060A2 (en) |
| JP (1) | JP2001521891A (en) |
| KR (1) | KR20010031577A (en) |
| CN (1) | CN1278178A (en) |
| AR (1) | AR043071A1 (en) |
| AU (1) | AU1206799A (en) |
| BG (1) | BG104436A (en) |
| BR (1) | BR9813318A (en) |
| CA (1) | CA2307850A1 (en) |
| HU (1) | HUP0100012A3 (en) |
| IL (1) | IL135518A0 (en) |
| NO (1) | NO20002189L (en) |
| PL (1) | PL340604A1 (en) |
| SK (1) | SK6172000A3 (en) |
| TR (1) | TR200001147T2 (en) |
| WO (1) | WO1999022722A2 (en) |
| ZA (1) | ZA989885B (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2338212T3 (en) | 2000-04-13 | 2010-05-05 | Biotica Technology Limited | HYBRID GLYCOSILATED PRODUCTS AND THEIR PRODUCTION AND USE. |
| AU2003272471B2 (en) | 2002-09-18 | 2010-10-07 | Trustees Of The University Of Pennsylvania | Method of inhibiting choroidal neovascularization |
| AR043050A1 (en) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| JP4928937B2 (en) | 2003-03-28 | 2012-05-09 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | Migrastatin analogs and uses thereof |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| JP2007505932A (en) | 2003-09-18 | 2007-03-15 | マクサイト， インコーポレイテッド | Transscleral delivery |
| US7087237B2 (en) * | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| EP1723159B1 (en) * | 2004-02-27 | 2019-06-12 | Melinta Therapeutics, Inc. | Macrocyclic compounds and methods of making and using the same |
| CN1950388A (en) * | 2004-02-27 | 2007-04-18 | 瑞伯-X医药品有限公司 | Macrocyclic compounds and methods of making and using the same |
| JP5149001B2 (en) | 2004-05-25 | 2013-02-20 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | Migrastatin analogues in the treatment of cancer |
| CA2582766C (en) | 2004-09-23 | 2014-07-22 | Sloan-Kettering Institute For Cancer Research | Isomigrastatin analogs in the treatment of cancer |
| AU2006213673A1 (en) | 2005-02-09 | 2006-08-17 | Santen Pharmaceutical Co., Ltd. | Formulations for ocular treatment |
| CA2615990A1 (en) | 2005-07-18 | 2007-01-25 | Minu, L.L.C. | Enhanced ocular neuroprotection/neurostimulation |
| US8470985B2 (en) | 2005-08-24 | 2013-06-25 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| ES2638427T3 (en) | 2005-08-24 | 2017-10-20 | Melinta Therapeutics, Inc. | Triazole compounds and preparation and use procedures |
| BRPI0707612B8 (en) | 2006-02-09 | 2021-05-25 | Macusight Inc | sealed vessel and liquid formulations contained therein |
| US8222271B2 (en) | 2006-03-23 | 2012-07-17 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
| CN106317146B (en) * | 2015-06-18 | 2019-06-21 | 沈阳药科大学 | Bicyclic clarithromycin derivatives and their use as tumor cell proliferation inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6461090A (en) * | 1989-10-30 | 1991-05-02 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
| US5498424A (en) * | 1994-11-30 | 1996-03-12 | Klein; Ira | Method of treating obesity |
-
1998
- 1998-10-29 AR ARP980105434A patent/AR043071A1/en unknown
- 1998-10-29 ZA ZA989885A patent/ZA989885B/en unknown
- 1998-10-30 CA CA002307850A patent/CA2307850A1/en not_active Abandoned
- 1998-10-30 EP EP98955206A patent/EP1027060A2/en not_active Withdrawn
- 1998-10-30 AU AU12067/99A patent/AU1206799A/en not_active Abandoned
- 1998-10-30 PL PL98340604A patent/PL340604A1/en unknown
- 1998-10-30 IL IL13551898A patent/IL135518A0/en unknown
- 1998-10-30 BR BR9813318-7A patent/BR9813318A/en not_active Application Discontinuation
- 1998-10-30 TR TR2000/01147T patent/TR200001147T2/en unknown
- 1998-10-30 SK SK617-2000A patent/SK6172000A3/en unknown
- 1998-10-30 KR KR1020007004625A patent/KR20010031577A/en not_active Ceased
- 1998-10-30 WO PCT/US1998/023043 patent/WO1999022722A2/en not_active Ceased
- 1998-10-30 JP JP2000518656A patent/JP2001521891A/en not_active Withdrawn
- 1998-10-30 HU HU0100012A patent/HUP0100012A3/en unknown
- 1998-10-30 CN CN98810825A patent/CN1278178A/en active Pending
-
2000
- 2000-04-27 NO NO20002189A patent/NO20002189L/en unknown
- 2000-05-15 BG BG104436A patent/BG104436A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1206799A (en) | 1999-05-24 |
| CN1278178A (en) | 2000-12-27 |
| WO1999022722A2 (en) | 1999-05-14 |
| HUP0100012A3 (en) | 2003-07-28 |
| NO20002189L (en) | 2000-06-28 |
| BG104436A (en) | 2000-12-29 |
| AR043071A1 (en) | 2005-07-20 |
| IL135518A0 (en) | 2001-05-20 |
| EP1027060A2 (en) | 2000-08-16 |
| ZA989885B (en) | 1999-05-05 |
| PL340604A1 (en) | 2001-02-12 |
| CA2307850A1 (en) | 1999-05-14 |
| HUP0100012A2 (en) | 2001-05-28 |
| JP2001521891A (en) | 2001-11-13 |
| WO1999022722A3 (en) | 1999-08-05 |
| KR20010031577A (en) | 2001-04-16 |
| TR200001147T2 (en) | 2000-08-21 |
| BR9813318A (en) | 2000-08-22 |
| SK6172000A3 (en) | 2001-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002189L (en) | Use of macrolides for the treatment of cancer and mucous degeneration | |
| NO991700D0 (en) | Benzimidazole-2-carbamates for the treatment of viral infections and cancer | |
| NO971015D0 (en) | Compounds and Methods for the Treatment of Cancer | |
| NO20004098D0 (en) | Methods and preparations for the treatment of macrophage-mediated disorders | |
| FI970990A7 (en) | Cancer detection and treatment | |
| GB9903841D0 (en) | Diagnosis and treatment of cancer | |
| HUP9904361A3 (en) | Use of isobutylgaba and its derivatives for the treatment of pain | |
| NO994778L (en) | Methods and Preparations for the Treatment of Inflammatory Bowel Syndrome | |
| NO991701D0 (en) | HIV and cancer treatment | |
| NO986089D0 (en) | Methods and preparations for the treatment of tumors, tumor-related diseases and o | |
| DE69836008D1 (en) | COMPOSITION AND TREATMENT AGENT | |
| NO20015516D0 (en) | Preparations and uses of ET743 for the treatment of cancer | |
| IL127739A0 (en) | Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases | |
| NO20015542D0 (en) | Process for the preparation and use of N-desmethylzopiclones | |
| DE69836209D1 (en) | PREVENTION AND TREATMENT OF HEPATOCELLULAR CANCER | |
| NO20003229L (en) | Combination of benzocycloheptapyridine compounds and antineoplastic agents for the treatment of proliferative diseases | |
| FI951060L (en) | Formulations and treatment methods | |
| NO983512D0 (en) | Means for the treatment and prevention of AIDS | |
| PT932400E (en) | DERIVATIVES OF USED ANTICONVULSIONERS IN THE TREATMENT OF NEUROPATIC PAIN | |
| GB9811598D0 (en) | Diagnosis and treatment of cancer | |
| NO994631D0 (en) | Procedures and compositions for the treatment of ovarian cancer | |
| IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
| IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
| EE200300057A (en) | Ingredients for the prevention and treatment of cancer | |
| NO985068L (en) | Vaccines for the treatment of lymphoma and leukemia |